159 related articles for article (PubMed ID: 33979042)
1. Comprehensive analysis of Syk gene methylation in colorectal cancer.
Bu F; Zhu X; Liu S; Lin K; Zhu J; Huang J
Immun Inflamm Dis; 2021 Sep; 9(3):923-931. PubMed ID: 33979042
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.
Yang Z; Huo L; Chen H; Ni B; Xiang J; Kang L; Wang L; Peng J; Yuan Y; Wang J
Med Oncol; 2013; 30(2):586. PubMed ID: 23609194
[TBL] [Abstract][Full Text] [Related]
3. Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation.
Biswas P; Dey D; Rahman A; Islam MA; Susmi TF; Kaium MA; Hasan MN; Rahman MDH; Mahmud S; Saleh MA; Paul P; Rahman MR; Al Saber M; Song H; Rahman MA; Kim B
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575665
[TBL] [Abstract][Full Text] [Related]
4. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
5. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
6. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between hypermethylation of Syk gene promoter and medulloblastoma cell invasion and metastasis].
Ji HL; Shi PF; Zhou J; Mao TM; Luo YK; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):132-136. PubMed ID: 29931864
[TBL] [Abstract][Full Text] [Related]
8. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
9. [Association between hypermethylation of Syk gene and clinicopathological characteristics in colorectal cancer patients].
Yang ZL; Wang L; Kang L; Peng JS; Xiang J; Huang MJ; Wang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):458-61. PubMed ID: 18803050
[TBL] [Abstract][Full Text] [Related]
10. Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells.
Denis V; Cassagnard N; Del Rio M; Cornillot E; Bec N; Larroque C; Jeanson L; Jarlier M; Combès E; Robert B; Gongora C; Martineau P; Dariavach P
PLoS One; 2022; 17(9):e0274390. PubMed ID: 36103569
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Immunological Role of THBS2 in Colorectal cancer.
Deng B; Liu XP; Wang X
Biomed Res Int; 2021; 2021():1124985. PubMed ID: 34471634
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
14. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
15. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel DNA hypermethylation of the adenylate kinase 5 promoter in colorectal adenocarcinoma.
Ahn B; Chae YS; Lee SK; Kim M; Kim HS; Moon JW; Park SH
Sci Rep; 2021 Jun; 11(1):12626. PubMed ID: 34135408
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
[TBL] [Abstract][Full Text] [Related]
19. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.
Moon JW; Lee SK; Lee JO; Kim N; Lee YW; Kim SJ; Kang HJ; Kim J; Kim HS; Park SH
J Exp Clin Cancer Res; 2014 Jan; 33(1):4. PubMed ID: 24393480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
